Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale N Gerding

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Infection Control and Hospital Epidemiology|March 24, 2010
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)Stuart H Cohen, Dale N Gerding, Stuart Johnson, et al.
The New England Journal of Medicine|December 3, 2005
An epidemic, toxin gene-variant strain of Clostridium difficileL Clifford McDonald, George E Killgore, Angela Thompson, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Epidemiology of <i>Clostridioides difficile</i> infection at one hospital 10 years after an outbreak of the epidemic <i>C. difficile</i> strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposuresJeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2019
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY IIEllie J C Goldstein, Diane M Citron, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile InfectionThomas Louie, Carl Erik Nord, George H Talbot, et al.
BMC Infectious Diseases|April 23, 2016
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databasesMargaret A Olsen, Yinong Young-Xu, Dustin Stwalley, et al.
Infection Control and Hospital Epidemiology|November 28, 2002
Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitalsEndale T Mekonen, Dale N Gerding, Susan P Sambol, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Effect of the COVID-19 Pandemic on Rates and Epidemiology of <i>Clostridioides difficile</i> Infection in One VA HospitalLorinda M Wright, Andrew M Skinner, Adam Cheknis, et al.
Infection Control and Hospital Epidemiology|February 9, 2018
Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration SystemAshley E Kates, Jessica S Tischendorf, Marin Schweizer, et al.
Journal of Clinical Microbiology|July 11, 2006
Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in HospitalsJane W Marsh, Mary M O'Leary, Kathleen A Shutt, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Infection Control and Hospital Epidemiology|March 24, 2010
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)Stuart H Cohen, Dale N Gerding, Stuart Johnson, et al.
The New England Journal of Medicine|December 3, 2005
An epidemic, toxin gene-variant strain of Clostridium difficileL Clifford McDonald, George E Killgore, Angela Thompson, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Epidemiology of <i>Clostridioides difficile</i> infection at one hospital 10 years after an outbreak of the epidemic <i>C. difficile</i> strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposuresJeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2019
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY IIEllie J C Goldstein, Diane M Citron, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile InfectionThomas Louie, Carl Erik Nord, George H Talbot, et al.
BMC Infectious Diseases|April 23, 2016
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databasesMargaret A Olsen, Yinong Young-Xu, Dustin Stwalley, et al.
Infection Control and Hospital Epidemiology|November 28, 2002
Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitalsEndale T Mekonen, Dale N Gerding, Susan P Sambol, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Effect of the COVID-19 Pandemic on Rates and Epidemiology of <i>Clostridioides difficile</i> Infection in One VA HospitalLorinda M Wright, Andrew M Skinner, Adam Cheknis, et al.
Infection Control and Hospital Epidemiology|February 9, 2018
Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration SystemAshley E Kates, Jessica S Tischendorf, Marin Schweizer, et al.
Journal of Clinical Microbiology|July 11, 2006
Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in HospitalsJane W Marsh, Mary M O'Leary, Kathleen A Shutt, et al.
Pageof 20